INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 424m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Public company

ICUIICU MEDICAL INC/DE

CIK 0000883984

EDGAR filingsOpen in network
Disclosed transactions23
Buys / sells0 / 8
Max Insider Score40
Connections5with evidence

ICUI · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL$1.12M
6,381 sh
Sep 1, 2026Sep 1, 2026
traded Sep 1, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Bonnell Brian MichaelChief Financial Officer · Aug 31, 2026
  • ← Insider ofevidence
    Hernandez LaurieDirector · May 13, 2026
  • ← Insider ofevidence
    Sousa BenChief Information Officer · Mar 9, 2026
15
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL
$792K
4,568 sh
Aug 31, 2026
Aug 31, 2026
traded Aug 31, 2026
+0d
SEC FORM 4

Evidence

11
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL$293K
1,712 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

11
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL$329K
1,914 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

8
BM
Bonnell Brian MichaelChief Financial Officer
ICUIICU MEDICAL INC/DE
Open-market sale · 10b5-1 plan
SELL$194K
1,113 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

36
WD
Woolson DanielVP, GM-Infusion Capital
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$982K
5,417 sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC FORM 4

Evidence

40
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$401K
2,250 sh
Aug 12, 2026Aug 12, 2026
traded Aug 12, 2026
+0dSEC FORM 4

Evidence

9
HL
Hernandez LaurieDirector
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,254 sh
May 13, 2026May 13, 2026
traded May 13, 2026
+0dSEC FORM 4

Evidence

17
HL
Hernandez LaurieDirector
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,254 sh
May 13, 2026May 13, 2026
traded May 13, 2026
+0dSEC FORM 4

Evidence

9
HL
Hernandez LaurieDirector
ICUIICU MEDICAL INC/DE
Grant or award
A—
1,475 sh
May 13, 2026May 13, 2026
traded May 13, 2026
+0dSEC FORM 4

Evidence

17
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,300 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

16
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Tax withholding
F$90K
718 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

9
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,300 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC FORM 4

Evidence

21
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
7,177 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

27
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Tax withholding
F$524K
3,967 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

21
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,409 sh
Mar 7, 2026Mar 9, 2026
traded Mar 7, 2026
+2dSEC FORM 4

Evidence

24
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Tax withholding
F$103K
782 sh
Mar 7, 2026Mar 9, 2026
traded Mar 7, 2026
+2dSEC FORM 4

Evidence

16
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Tax withholding
F$70K
529 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

17
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
1,409 sh
Mar 7, 2026Mar 9, 2026
traded Mar 7, 2026
+2dSEC FORM 4

Evidence

17
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
957 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

9
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
7,177 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

17
SB
Sousa BenChief Information Officer
ICUIICU MEDICAL INC/DE
Option exercise
M—
957 sh
Mar 8, 2026Mar 9, 2026
traded Mar 8, 2026
+1dSEC FORM 4

Evidence

35
WD
Woolson DanielVP, GM-Infusion Capital
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$441K
2,897 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Woolson DanielVP, GM-Infusion Capital · Nov 25, 2025